Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.04 | 0.9 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |